Global Pruritus Therapeutics Market is expected to reach USD 16.38
Billion by 2025, according to a new study by Grand View Research, Inc. Growing
worldwide prevalence of atopic dermatitis, allergic contact dermatitis and
urticaria is expected to drive market growth during the forecast period.
Introduction of new products based on scientific mechanistic understanding such
as the identification of new T-cell subsets, particularly Th17, and Th22 and
the patent expiration of PROTOPIC (tacrolimus) is expected to open up new
avenues for manufacturers to capitalize on over the forecast period.
Corticosteroids were the leading product segment in 2013 owing to high
efficacy exhibited by this class of drugs in treating pruritic conditions by
reducing inflammation and itching. Topical applications of corticosteroids have
been found to be extremely effective in the treatment and maintenance therapies
pertaining to pruritus.
In depth research report
on Pruritus Therapeutics Market
Further key findings from
the study suggest:
·
Calcineurin inhibitor is identified as the most lucrative segment of the
market on account of high usage rate of these drugs in combination therapy for
the treatment of pruritus in patients suffering from chronic pruritus and
growing market penetration rates. Moreover, the introduction of new products
such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive
this market.
·
Anti-histamines owing to its growing use as a first line treatment and
presence of drugs in pipeline with expected commercialization is also expected
to grow at a healthy rate during the forecast period.
·
North America led the overall market in terms of revenue in 2013 majorly
on account of the presence of high prevalence of diseases associated with
pruritus, introduction of new products targeting the unmet medical needs and
growing patient awareness levels.
·
The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR
of over 5.0% during the forecast period. Presence of high unmet healthcare
needs and increasing prevalence of allergic contact dermatitis and urticaria in
this region are some factors attributing to its rapid growth rate.
·
Some key participants of the pruritus therapeutics market include Sanofi,
Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara
Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
·
Manufacturers adhere to rigorous R&D in an attempt to develop cost
effective products and avoid barriers such as product recalls. In addition,
this strategy is implemented keeping the unmet needs in consideration. For
Instance, Creabilis has a molecule in the pipeline – CT327, which caters to the
unmet needs associated with pruritus in patients suffering from psoriasis.
For the purpose of this study, Grand View Research has segmented the
global pruritus therapeutics market on the basis of product, disease type and
region:
Global Pruritus
Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
·
Corticosteroids
·
Antihistamines
·
Local Anesthetics
·
Counterirritants
·
Immunosuppressant
·
Calcineurin Inhibitors
·
Others
Global Pruritus
Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
·
Atopic Dermatitis
·
Allergic Contact Dermatitis
·
Urticaria
·
Others
Global Pruritus
Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)
·
North America
o
U.S.
o
Rest of North America
·
Europe
o
Germany
o
UK
o
France
o
Italy
o
Spain
o
Rest of Europe
·
Asia Pacific
o
Japan
·
Rest of Asia Pacific
o
RoW
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment